BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3459939)

  • 1. [HLA and thyroid cancer].
    Dralle H; Robin-Winn M; Reilmann L; Laue A; Török M
    Klin Wochenschr; 1986 Jun; 64(11):522-5. PubMed ID: 3459939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strong association between an HLA-DR antigen and thyroid carcinoma.
    Panza N; Del Vecchio L; Maio M; De Felice M; Lombardi G; Minozzi M; Zappacosta S
    Tissue Antigens; 1982 Aug; 20(2):155-8. PubMed ID: 6814009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of differentiated thyroid carcinoma with HLA-DR7.
    Sridama V; Hara Y; Fauchet R; DeGroot LJ
    Cancer; 1985 Sep; 56(5):1086-8. PubMed ID: 3874685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.
    Jo YS; Lee JC; Li S; Choi YS; Bai YS; Kim YJ; Lee IS; Rha SY; Ro HK; Kim JM; Shong M
    Int J Cancer; 2008 Feb; 122(4):785-90. PubMed ID: 17957790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR association in papillary thyroid carcinoma.
    Amoli MM; Yazdani N; Amiri P; Sayahzadeh F; Haghpanah V; Tavangar SM; Amirzargar A; Ghaffari H; Nikbin B; Larijani B; Mostaan LV; Bazzaz JT
    Dis Markers; 2010; 28(1):49-53. PubMed ID: 20164547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HLA-A, B, C and DR antigens in exogenous allergic alveolitis--association with HLA-DRw6].
    Kusber M
    Prax Klin Pneumol; 1985 Oct; 39(10):356-9. PubMed ID: 3877921
    [No Abstract]   [Full Text] [Related]  

  • 7. [Familial occurrence of differentiated, non-medullary thyroid carcinoma].
    Ozaki O; Ito K; Eto M; Kobayashi K; Suzuki A; Manabe Y; Hosoda Y
    Nihon Gan Chiryo Gakkai Shi; 1987 May; 22(4):809-17. PubMed ID: 3668355
    [No Abstract]   [Full Text] [Related]  

  • 8. Human leukocyte antigen associations in basal cell carcinoma.
    Myskowski PL; Pollack MS; Schorr E; Dupont B; Safai B
    J Am Acad Dermatol; 1985 Jun; 12(6):997-1000. PubMed ID: 3874217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA antigens in patients with and without a family history of schizophrenia.
    Rudduck C; Franzén G; Löw B; Rorsman B
    Hum Hered; 1984; 34(5):291-6. PubMed ID: 6592138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HLA DQ4-DR8 haplotype with papillary thyroid carcinomas.
    Porto T; Coelho I; Boavida J; Pereira C; Nunes JM; Mendonça D; Martins B; Sobrinho LG; Leite V
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):179-83. PubMed ID: 16430717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenetic and immunologic studies of differentiated thyroid cancer.
    Juhasz F; Boros P; Szegedi G; Balazs G; Suranyi P; Kraszits E; Stenszky V; Farid NR
    Cancer; 1989 Apr; 63(7):1318-26. PubMed ID: 2784072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-antigens in the Egyptian population.
    Hafez M; el-Shennawy FA
    Forensic Sci Int; 1986 Jul; 31(4):241-6. PubMed ID: 3462103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA antigens, autoantibodies and clinical subsets in scleroderma.
    Black CM; Welsh KI; Maddison PJ; Jayson MI; Bernstein RM
    Br J Rheumatol; 1984 Nov; 23(4):267-71. PubMed ID: 6593111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA and DR antigen frequencies in melanoma patients: possible relation to disease prognosis.
    Pollack MS; Livingston PO
    Tissue Antigens; 1985 Oct; 26(4):262-5. PubMed ID: 3878014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial occurrence of differentiated, nonmedullary thyroid carcinoma.
    Ozaki O; Ito K; Kobayashi K; Suzuki A; Manabe Y; Hosoda Y
    World J Surg; 1988 Aug; 12(4):565-71. PubMed ID: 3048001
    [No Abstract]   [Full Text] [Related]  

  • 16. Associations between HLA-C alleles and papillary thyroid carcinoma.
    Haghpanah V; Khalooghi K; Adabi K; Amiri P; Tavangar SM; Amirzargar A; Ghaffari H; Yazdani N; Nikbin B; Larijani B; Amoli MM
    Cancer Biomark; 2009; 5(1):19-22. PubMed ID: 19242058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA and Kaposi's sarcoma in Sardinia.
    Contu L; Cerimele D; Pintus A; Cottoni F; La Nasa G
    Tissue Antigens; 1984 Apr; 23(4):240-5. PubMed ID: 6587615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetics of Crohn disease: study of the HLA association in 169 patients].
    Korsten S; Purrmann J; Bertrams J; Reis HE; Miller B; Münch H; Korsten FW; Strohmeyer G
    Klin Wochenschr; 1985 Aug; 63(16):747-51. PubMed ID: 3862913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA antigens in Asian Indians: HLA-D-DR relationships.
    Suciu-Foca N; Reed E; Khan R; Coburn C; Lewison A; Hassanali R; Rohowsky C; Susinno E; Reemtsma K
    Hum Immunol; 1981 Nov; 3(3):261-70. PubMed ID: 6946986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA immunogenetic heterogeneity in black American patients with Graves' disease.
    Sridama V; Hara Y; Fauchet R; DeGroot LJ
    Arch Intern Med; 1987 Feb; 147(2):229-31. PubMed ID: 3468887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.